Abstract:Objective To provide clues for the study on the mechanism of autoimmune liver disease (AILD) by exploring the existence of specific bacteria in liver tissues of AILD patients.Methods From August 2017 to August 2018,at Department of Gastroenterology arnd Hepatology,Tianjin Medical University General Hospital,a total of 12 patients diagnosed as AILD (four autoimmune hepatitis (AIH),four primary biliary cirrhosis (PBC) and four PBC-AIH overlap syndrome (OS)) and four patients with hepatic cyst (control group) were enrolled and all the patients underwent liver biopsy.16S rRNA gene sequencing was carried out in the obtained aseptic liver tissues.Linear discriminant analysis effect size was used to find out the specific bacteria.Spearman correlation analysis was performed to analyze the correlation between the liver microbiota and the disease.The metabolic function of the 16S rRNA gene sequences was also predicted.Results Bacteria were detected in the liver tissues of all the 16 patients.At the species level,the abundance of Planococcus rifietoensis of AIH group was 0.100％,which was higher than those of other three groups (0),and the difference was statistically significant (linear discriminant analysis (LDA) =3.31,P =0.034).The abundance of Anoxybacillus flavithermus of PBC group was 0.200％,which was higher than those of other three groups (0.100％),and the difference was statistically significant (LDA =3.34,P =0.014).The abundance of Pseudomonas aeruginosa PAO1,Bacillus firmus,Brevibacillus agri,Acinetobacter baumannii,Sphingomonas zeae and Salmonella enterica were significantly negatively correlated with serum level of γ-glutamyl transferase (r=-0.68,-0.68,-0.67,-0.68,-0.68 and-0.66,all P ＜0.01).Compared with that of the hepatic cyst group,the lipid metabolism of AILD patients decreased.The levels of serum low density lipoprotein and total cholesterol were significantly negatively correlated with the biosynthesis of unsaturated fatty acids (r =-0.55 and-0.65,both P ＜ 0.05).Conclusions There exist specific bacteria in the liver tissues of AIH and PBC groups.The liver microbiota which is closely related with the pathogenesis of AILD might be a potential therapeutic target and diagnostic biomarker.

Alterations of gut microbiome in autoimmune hepatitis

A Serum Metabolomic Analysis for Diagnosis and Biomarker Discovery of Primary Biliary Cirrhosis and Autoimmune Hepatitis.

The Gut Microbiota: A Novel Player in Autoimmune Hepatitis

The significance of gut microbiota in the etiology of autoimmune hepatitis: a narrative review

Intestinal microbiome and permeability in patients with autoimmune hepatitis

Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals.

The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes

Preliminary Study on Abundance and Diversity of Microbiota in Liver Tissues of Patients with Autoimmune Liver Disease

Oral Microbiome Characteristics in Patients With Autoimmune Hepatitis

Intestinal Homeostasis in Autoimmune Liver Diseases

Implications of Gut Microbiota in Autoimmune Liver Diseases

Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis

Autoimmune Hepatitis: Shifts in Gut Microbiota and Metabolic Pathways among Egyptian Patients

Intestinal Microbiota Was Assessed in Cirrhotic Patients with Hepatitis B Virus Infection

Gut microbiota dysbiosis associated with plasma levels of Interferon-gamma and viral load in patients with acute hepatitis E infection

Bifidobacterium animalis ssp. Lactis 420 Mitigates Autoimmune Hepatitis Through Regulating Intestinal Barrier and Liver Immune Cells

Genetically predicted immune cells mediate the association between gut microbiota and autoimmune liver diseases

Dysregulation and impaired anti-bacterial potential of mucosal-associated invariant T cells in autoimmune liver diseases

Lactobacillus Improves the Effects of Prednisone on Autoimmune Hepatitis Via Gut Microbiota-Mediated Follicular Helper T Cells

Metabolomic Signatures of Autoimmune Hepatitis in the Development of Cirrhosis